Replies to post #199218 on Biotech Values

[DewDiligence]

VTVT completes enrollment of phase-2b trial for TTP399 in T2D:

http://finance.yahoo.com/news/vtv-therapeutics-completes-enrollment-phase-210500998.html

Top-line data will be reported in mid 2016.

Note: This trial is not to be confused with the phase-2 trial of TTP273 in T2D, which began a few weeks ago (#msg-119980964).

[DewDiligence]

VTVT completes enrollment of TTP273 phase-2 trial in T2D:

http://finance.yahoo.com/news/vtv-therapeutics-completes-enrollment-phase-110000776.html

Note: TTP273 is not to be confused with TTP399, a separate T2D program, where phase-2b enrollment was completed in February (#msg-120423171). Both T2D programs are expected to report data during 2016.